(Q38887162)

English

The principal pathways involved in the in vivo modulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

The principal pathways involved in the in vivo modulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

0 references

vasoconstriction

1 reference

based on heuristic

inferred from title

author name string

D Kylhammar

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

G Rådegran

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

6 July 2016

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Acta Physiologica

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

219

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

728-756

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Endothelium-derived mediators and hypoxic pulmonary vasoconstriction

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Variability of hypoxic pulmonary vasoconstriction in sheep. Role of prostaglandins.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Cyclo-oxygenase products mediate hypoxic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

ZK 36-374, a stable analog of prostacyclin, prevents acute hypoxic pulmonary hypertension in the dog.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Luminal ATP-induced contraction of rabbit pulmonary arteries and role of purinoceptors in the regulation of pulmonary arterial pressure

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Stimulus-response curves for the pulmonary vascular bed to hypoxia and hypercapnia

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Effects of alveolar hypoxia on lung fluid and protein transport in unanesthetized sheep

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Influence of thromboxane A2 receptor antagonism on pulmonary vasoconstrictor responses.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

P1-purinoceptor-mediated vasodilatation and vasoconstriction in hypoxia

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Determinants of maximal oxygen uptake in severe acute hypoxia.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

The role of angiotensin II receptor-1 blockade in the hypoxic pulmonary vasoconstriction response in newborn piglets

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Hypoxaemia and release of endothelin-1

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Regional variation in P2 receptor expression in the rat pulmonary arterial circulation

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Multiple P2Y receptors couple to calcium-dependent, chloride channels in smooth muscle cells of the rat pulmonary artery.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

The endothelin A receptor antagonists PD 156707 (CI-1020) and PD 180988 (CI-1034) reverse the hypoxic pulmonary vasoconstriction in the perinatal lamb

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Exaggerated hypoxic pulmonary vasoconstriction without susceptibility to high altitude pulmonary edema.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Haemodynamic effects of ATP in dogs during hypoxia-induced pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Hypoxia-induced pulmonary endothelin-1 expression is unaltered by nitric oxide

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Unilateral hypoxic pulmonary vasoconstriction in the dog, pony and miniature swine.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

The red blood cell as an oxygen sensor: what is the evidence?

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Vasoreactions to acute hypoxia, whole lungs and isolated vessels compared: modulation by NO.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Observations on the Pulmonary Arterial Blood Pressure in the Cat

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Bosentan decreases pulmonary vascular resistance and improves exercise capacity in acute hypoxia

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Endothelium-mediated control of vascular tone: COX-1 and COX-2 products

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Cardioprotective prostacyclin signaling in vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Thromboxane inhibition reduces an early stage of chronic hypoxia-induced pulmonary hypertension in piglets

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Selective or nonselective endothelin antagonists in porcine hypoxic pulmonary hypertension?

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Hypoxia-induced secretion of serotonin from intact pulmonary neuroepithelial bodies in neonatal rabbit

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Role of veins in regulation of pulmonary circulation

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Regulation of the Pulmonary Circulation in the Fetus and Newborn

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Intravenous tezosentan and vardenafil attenuate acute hypoxic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Influence of an antagonist of slow-reacting substance of anaphylaxis on the cardiovascular manifestations of hypoxia in piglets.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Extracellular ATP: effects, sources and fate

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Efficacy of CI-1020, an endothelin-A receptor antagonist, in hypoxic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Role of histamine in the hypoxic vascular response of the lung

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Interacting roles of nitric oxide and ATP in the pulmonary circulation of the rat.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Effects of hypercapnia with and without acidosis on hypoxic pulmonary vasoconstriction.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Changes in pulmonary vascular tone during exercise. Effects of nitric oxide (NO) synthase inhibition, L-arginine infusion, and NO inhalation

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Systemic and myocardial effects of ATP and adenosine during hypoxic pulmonary hypertension in lambs.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Selective pulmonary vasodilation by low-dose infusion of adenosine triphosphate in newborn lambs.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

P2Y purine receptor responses and expression in the pulmonary circulation of juvenile rabbits

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Influence of cyclo-oxygenase inhibition and of leukotriene receptor blockade on pulmonary vascular pressure/cardiac index relationships in hyperoxic and in hypoxic dogs.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Attenuated hypoxic pulmonary vasoconstriction during isoflurane anesthesia is abolished by cyclooxygenase inhibition in chronically instrumented dogs.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ET(A) receptor-selective antagonist

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Renin-angiotensin system inhibition in conscious dogs during acute hypoxemia. Effects on systemic hemodynamics, regional blood flows, and tissue metabolism

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

5-HT1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: influences of vascular endothelium and tone.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

The contrasting influence of two lipoxygenase inhibitors on hypoxic pulmonary vasoconstriction in anesthetized pigs.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Purinoceptors in the pulmonary circulation of the rat and their role in hypoxic vasoconstriction

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Leukotriene C4 production during hypoxic pulmonary vasoconstriction in isolated rat lungs

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Regulation of the skeletal muscle blood flow in humans

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Pulmonary hypertension and the right ventricle in hypoxia

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Prostacyclin synthase in smoking-related lung disease.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Coronary artery reperfusion: The ADP receptor P2Y(1) mediates early reactive hyperemia in vivo in pigs

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Highlights on endothelins: a review

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Adenosine triphosphate: a potential therapy for hypoxic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Adenosine triphosphate (ATP) treatment of hypoxic pulmonary hypertension (HPH): comparison of dose dependence in pulmonary and renal circulations.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Vascular endothelial cells synthesize nitric oxide from L-arginine

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Leukotriene synthesis inhibition and receptor blockade do not inhibit hypoxic pulmonary vasoconstriction in sheep

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Endothelin receptors blockade blunts hypoxia-induced increase in PAP in humans

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Bosentan effects in hypoxic pulmonary vasoconstriction: Preliminary study in subjects with or without high altitude pulmonary edema-history

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Efficacy of tadalafil in chronic hypobaric hypoxia-induced pulmonary hypertension: possible mechanisms.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Histamine and hypoxic pulmonary hypertension. A quantitative study

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Regulation of vascular tone by UTP and UDP in isolated rat intrapulmonary arteries

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Endogenous NO does not regulate baseline pulmonary pressure, but reduces acute pulmonary hypertension in dogs

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

New insights in the pathogenesis of high-altitude pulmonary edema

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Leukotriene inhibition prevents and reverses hypoxic pulmonary vasoconstriction in newborn lambs.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Pulmonary hypertension in chronic lung diseases

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

The effect of the ETA receptor antagonist (CI-1020) in rats with established hypoxic pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

COX and the control of the pulmonary circulation

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Failure of an antagonist of histamine--chlorpheniramine--to modify the pulmonary vascular response to hypoxia in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

A randomised, controlled trial of bosentan in severe COPD.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sildenafil acutely reverses the hypoxic pulmonary vasoconstriction response of the newborn pig.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Endothelin-1 in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Involvement of endothelin-1 in hypoxic pulmonary vasoconstriction in the lamb

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Basic features of hypoxic pulmonary vasoconstriction in mice

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Stimulation of soluble guanylate cyclase prevents cigarette smoke-induced pulmonary hypertension and emphysema

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

PGI2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction.

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

A novel and selective endothelin ET(A) receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

ATP-induced mitogenesis is mediated by cyclic AMP response element-binding protein-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Sildenafil inhibits hypoxia-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Images in cardiovascular medicine. High-altitude-induced right-heart failure

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Plasma Pro-Adrenomedullin But Not Plasma Pro-Endothelin Predicts Survival in Exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

BAY 41-2272, a Direct Activator of Soluble Guanylate Cyclase, Reduces Right Ventricular Hypertrophy and Prevents Pulmonary Vascular Remodeling during Chronic Hypoxia in Neonatal Rats

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Pulmonary artery pressure limits exercise capacity at high altitude

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Hypoxic pulmonary vasoconstriction

1 reference

https://api.crossref.org/works/10.1111%2FAPHA.12749

21 January 2018

Identifiers

10.1111/APHA.12749

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38887162&oldid=1794045253"